You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Tocilizumab for the treatment of rheumatoid arthritis

  • Technology appraisal guidance
  • Reference number: TA247
  • Published:  22 February 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA247 Rheumatoid arthritis - tocilizumab (rapid review TA198): Appendix A - decision paper presented to the Institute's Guidance Executive

TA247 Rheumatoid arthritis - tocilizumab (rapid review TA198): Appendix A - decision paper presented to the Institute's Guidance Executive TA247 Rheumatoid arthritis - tocilizumab (rapid review TA198): Appendix A - decision paper presented to the Institute's Guidance Executive
16 September 2013
(225.79 Kb 5 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 13 September 2013

Back to top